Mike is a shareholder and serves as Chair of the Venture Capital Practice Area Team. He is also a member of the LeClairRyan BioPharma and Energy Teams. He focuses his practice on and customarily acts as lead counsel in connection with debt and equity financings, mergers and acquisitions, strategic alliances, joint ventures, management buyouts, intellectual property licensing transactions and a variety of domestic and international transactions. Mike currently serves as general counsel to a number of emerging companies, including medical device, bioinformatics, pharmaceutical, diagnostics, manufacturing and distribution, alternative energy, medical information technology, internet, and high-tech research and development companies. He also serves as counsel to a growing angel investor network and has served on the board of directors of client companies. He also serves as a mentor at DayOne Ventures, a Blacksburg-based, invitation-only seed stage investment and mentorship program for technology-based startups.

Mike currently serves as general counsel to two pharmaceutical companies; three medical device companies; two bioinformatics companies; and a point of care medical data management company.

He has worked on the following transactions in the BioPharma industry: organization of companies; and employment and incentive compensation agreements; numerous rounds of financing, ranging from friends and family to institutional venture capital; sale of a BioPharma company; numerous licensing deals, including but not limited to outlicensing key science from a variety of universities; contract manufacturing agreements; and clinical trial agreements.